Global Microbiome Therapeutics Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 94578
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Microbiome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Microbiome Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 42.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 173.8 million by 2025, from USD 42 million in 2019.

Market segmentation

Microbiome Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Microbiome Therapeutics market has been segmented into Upper GIT, Lower GIT, etc.

Breakdown by Application, Microbiome Therapeutics has been segmented into Inflammatory Bowel Disease (IBD), Orphan Drug, Immuno-oncology, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Microbiome Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Microbiome Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Microbiome Therapeutics market.

For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Microbiome Therapeutics Market Share Analysis

Microbiome Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Microbiome Therapeutics revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Microbiome Therapeutics revenue and market share for each player covered in this report.

The major players covered in Microbiome Therapeutics are: Seres Therapeutics, 4D Pharma, Interxon, Assembly Biosciences, Enterome BioScience, Synthetic Biologics, AOBiome, Synlogic, PureTech, Second Genome, Ritter Pharmaceuticals, Azitra, C3 Jian, Osel, Symberix, Metabiomics, Rebiotix, Symbiotix Biotherapies, OpenBiome, MicroBiome Therapeutics LLC, Metabogen, etc. Among other players domestic and global, Microbiome Therapeutics market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Seres Therapeutics

4D Pharma

Interxon

Assembly Biosciences

Enterome BioScience

Synthetic Biologics

AOBiome

Synlogic

PureTech

Second Genome

Ritter Pharmaceuticals

Azitra

C3 Jian

Osel

Symberix

Metabiomics

Rebiotix

Symbiotix Biotherapies

OpenBiome

MicroBiome Therapeutics LLC

Metabogen

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Upper GIT

Lower GIT

Market segment by Application, can be divided into

Inflammatory Bowel Disease (IBD)

Orphan Drug

Immuno-oncology

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Microbiome Therapeutics

1.2 Classification of Microbiome Therapeutics by Type

1.2.1 Overview: Global Microbiome Therapeutics Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Microbiome Therapeutics Revenue Market Share by Type in 2019

1.2.3 Upper GIT

1.2.4 Lower GIT

1.3 Global Microbiome Therapeutics Market by Application

1.3.1 Overview: Global Microbiome Therapeutics Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Inflammatory Bowel Disease (IBD)

1.3.3 Orphan Drug

1.3.4 Immuno-oncology

1.3.5 Others

1.4 Global Microbiome Therapeutics Market Size and Forecast (2015-2025)

1.5 Global Microbiome Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Microbiome Therapeutics Market Size by Regions (2015-2020)

1.7 Global Microbiome Therapeutics Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Microbiome Therapeutics Status and Prospect (2015-2025)

1.7.2 Europe Microbiome Therapeutics Status and Prospect (2015-2025)

1.7.3 Asia Microbiome Therapeutics Status and Prospect (2015-2025)

1.7.4 South America Microbiome Therapeutics Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Microbiome Therapeutics Status and Prospect (2015-2025)

2 Company Profiles

2.1 Seres Therapeutics

2.1.1 Seres Therapeutics Details

2.1.2 Seres Therapeutics Major Business

2.1.3 Seres Therapeutics SWOT Analysis

2.1.4 Seres Therapeutics Product and Services

2.1.5 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.2 4D Pharma

2.2.1 4D Pharma Details

2.2.2 4D Pharma Major Business

2.2.3 4D Pharma SWOT Analysis

2.2.4 4D Pharma Product and Services

2.2.5 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.3 Interxon

2.3.1 Interxon Details

2.3.2 Interxon Major Business

2.3.3 Interxon SWOT Analysis

2.3.4 Interxon Product and Services

2.3.5 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.4 Assembly Biosciences

2.4.1 Assembly Biosciences Details

2.4.2 Assembly Biosciences Major Business

2.4.3 Assembly Biosciences SWOT Analysis

2.4.4 Assembly Biosciences Product and Services

2.4.5 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.5 Enterome BioScience

2.5.1 Enterome BioScience Details

2.5.2 Enterome BioScience Major Business

2.5.3 Enterome BioScience SWOT Analysis

2.5.4 Enterome BioScience Product and Services

2.5.5 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.6 Synthetic Biologics

2.6.1 Synthetic Biologics Details

2.6.2 Synthetic Biologics Major Business

2.6.3 Synthetic Biologics Product and Services

2.6.4 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.7 AOBiome

2.7.1 AOBiome Details

2.7.2 AOBiome Major Business

2.7.3 AOBiome Product and Services

2.7.4 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.8 Synlogic

2.8.1 Synlogic Details

2.8.2 Synlogic Major Business

2.8.3 Synlogic Product and Services

2.8.4 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.9 PureTech

2.9.1 PureTech Details

2.9.2 PureTech Major Business

2.9.3 PureTech Product and Services

2.9.4 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.10 Second Genome

2.10.1 Second Genome Details

2.10.2 Second Genome Major Business

2.10.3 Second Genome Product and Services

2.10.4 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.11 Ritter Pharmaceuticals

2.11.1 Ritter Pharmaceuticals Details

2.11.2 Ritter Pharmaceuticals Major Business

2.11.3 Ritter Pharmaceuticals Product and Services

2.11.4 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.12 Azitra

2.12.1 Azitra Details

2.12.2 Azitra Major Business

2.12.3 Azitra Product and Services

2.12.4 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.13 C3 Jian

2.13.1 C3 Jian Details

2.13.2 C3 Jian Major Business

2.13.3 C3 Jian Product and Services

2.13.4 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.14 Osel

2.14.1 Osel Details

2.14.2 Osel Major Business

2.14.3 Osel Product and Services

2.14.4 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.15 Symberix

2.15.1 Symberix Details

2.15.2 Symberix Major Business

2.15.3 Symberix Product and Services

2.15.4 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.16 Metabiomics

2.16.1 Metabiomics Details

2.16.2 Metabiomics Major Business

2.16.3 Metabiomics Product and Services

2.16.4 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.17 Rebiotix

2.17.1 Rebiotix Details

2.17.2 Rebiotix Major Business

2.17.3 Rebiotix Product and Services

2.17.4 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.18 Symbiotix Biotherapies

2.18.1 Symbiotix Biotherapies Details

2.18.2 Symbiotix Biotherapies Major Business

2.18.3 Symbiotix Biotherapies Product and Services

2.18.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.19 OpenBiome

2.19.1 OpenBiome Details

2.19.2 OpenBiome Major Business

2.19.3 OpenBiome Product and Services

2.19.4 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.20 MicroBiome Therapeutics LLC

2.20.1 MicroBiome Therapeutics LLC Details

2.20.2 MicroBiome Therapeutics LLC Major Business

2.20.3 MicroBiome Therapeutics LLC Product and Services

2.20.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

2.21 Metabogen

2.21.1 Metabogen Details

2.21.2 Metabogen Major Business

2.21.3 Metabogen Product and Services

2.21.4 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Microbiome Therapeutics Market Size by Players (2015-2020)

3.2 United States Microbiome Therapeutics Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Microbiome Therapeutics Players Market Share

3.3.2 Top 10 Microbiome Therapeutics Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Microbiome Therapeutics Market Size by Countries (2015-2020)

4.2 North America Microbiome Therapeutics Market Size and Forecast by Countries (2015-2026)

4.3 United States Microbiome Therapeutics Market Size and Forecast (2015-2025)

4.4 Canada Microbiome Therapeutics Market Size and Forecast (2015-2025)

4.5 Mexico Microbiome Therapeutics Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Microbiome Therapeutics Market Size by Countries (2015-2020)

5.2 Europe Microbiome Therapeutics Market Size and Forecast by Countries (2015-2026)

5.3 Germany Microbiome Therapeutics Market Size and Forecast (2015-2025)

5.4 France Microbiome Therapeutics Market Size and Forecast (2015-2025)

5.5 UK Microbiome Therapeutics Market Size and Forecast (2015-2025)

5.6 Russia Microbiome Therapeutics Market Size and Forecast (2015-2025)

5.7 Italy Microbiome Therapeutics Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Microbiome Therapeutics Market Size by Regions (2015-2020)

6.2 Asia-Pacific Microbiome Therapeutics Market Size and Forecast by Regions (2015-2026)

6.3 China Microbiome Therapeutics Market Size and Forecast (2015-2025)

6.4 Japan Microbiome Therapeutics Market Size and Forecast (2015-2025)

6.5 Korea Microbiome Therapeutics Market Size and Forecast (2015-2025)

6.6 India Microbiome Therapeutics Market Size and Forecast (2015-2025)

6.7 Southeast Asia Microbiome Therapeutics Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Microbiome Therapeutics Market Size by Countries (2015-2020)

7.2 South America Microbiome Therapeutics Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Microbiome Therapeutics Market Size and Forecast (2015-2025)

7.4 Argentina Microbiome Therapeutics Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Microbiome Therapeutics Revenue by Regions (2015-2020)

8.2 Middle East & Africa Microbiome Therapeutics Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Microbiome Therapeutics Market Size and Forecast (2015-2025)

8.4 UAE Microbiome Therapeutics Market Size and Forecast (2015-2025)

8.5 Egypt Microbiome Therapeutics Market Size and Forecast (2015-2025)

8.6 South Africa Microbiome Therapeutics Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Microbiome Therapeutics Market Size and Forecast by Type (2015-2025)

9.1.1 Global Microbiome Therapeutics Market Size by Type (2015-2020)

9.1.2 Global Microbiome Therapeutics Market Size Forecast by Type (2020-2025)

9.2 United States Microbiome Therapeutics Market Size and Forecast by Type (2015-2025)

9.2.1 United States Microbiome Therapeutics Market Size by Type (2015-2020)

9.2.2 United States Microbiome Therapeutics Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Microbiome Therapeutics Market Size and Forecast by Application (2015-2025)

10.1.1 Global Microbiome Therapeutics Market Size by Application (2015-2020)

10.1.2 Global Microbiome Therapeutics Market Size Forecast by Application (2020-2025)

10.2 United States Microbiome Therapeutics Market Size and Forecast by Application (2015-2025)

10.2.1 United States Microbiome Therapeutics Market Size by Application (2015-2020)

10.2.2 United States Microbiome Therapeutics Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Microbiome Therapeutics Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Microbiome Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Microbiome Therapeutics Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Microbiome Therapeutics Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Microbiome Therapeutics Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Microbiome Therapeutics Revenue Share by Regions (2015-2020)

Table 7. Global Microbiome Therapeutics Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Microbiome Therapeutics Revenue Market Share by Regions (2020-2025)

Table 9. Global Microbiome Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. Seres Therapeutics Corporate Information, Location and Competitors

Table 11. Seres Therapeutics Major Business

Table 12. Seres Therapeutics Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 13. Seres Therapeutics SWOT Analysis

Table 14. Seres Therapeutics Microbiome Therapeutics Product and Solutions

Table 15. Seres Therapeutics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. 4D Pharma Corporate Information, Location and Competitors

Table 17. 4D Pharma Major Business

Table 18. 4D Pharma Microbiome Therapeutics Total Revenue (USD Million) (2018-2019)

Table 19. 4D Pharma SWOT Analysis

Table 20. 4D Pharma Microbiome Therapeutics Product and Solutions

Table 21. 4D Pharma Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. Interxon Corporate Information, Location and Competitors

Table 23. Interxon Major Business

Table 24. Interxon Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 25. Interxon SWOT Analysis

Table 26. Interxon Microbiome Therapeutics Product and Solutions

Table 27. Interxon Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Assembly Biosciences Corporate Information, Location and Competitors

Table 29. Assembly Biosciences Major Business

Table 30. Assembly Biosciences Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 31. Assembly Biosciences SWOT Analysis

Table 32. Assembly Biosciences Microbiome Therapeutics Product and Solutions

Table 33. Assembly Biosciences Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. Enterome BioScience Corporate Information, Location and Competitors

Table 35. Enterome BioScience Major Business

Table 36. Enterome BioScience Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 37. Enterome BioScience SWOT Analysis

Table 38. Enterome BioScience Microbiome Therapeutics Product and Solutions

Table 39. Enterome BioScience Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Synthetic Biologics Corporate Information, Location and Competitors

Table 41. Synthetic Biologics Major Business

Table 42. Synthetic Biologics Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 43. Synthetic Biologics SWOT Analysis

Table 44. Synthetic Biologics Microbiome Therapeutics Product and Solutions

Table 45. Synthetic Biologics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. AOBiome Corporate Information, Location and Competitors

Table 47. AOBiome Major Business

Table 48. AOBiome Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 49. AOBiome SWOT Analysis

Table 50. AOBiome Microbiome Therapeutics Product and Solutions

Table 51. AOBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 52. Synlogic Corporate Information, Location and Competitors

Table 53. Synlogic Major Business

Table 54. Synlogic Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 55. Synlogic SWOT Analysis

Table 56. Synlogic Microbiome Therapeutics Product and Solutions

Table 57. Synlogic Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 58. PureTech Corporate Information, Location and Competitors

Table 59. PureTech Major Business

Table 60. PureTech Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 61. PureTech SWOT Analysis

Table 62. PureTech Microbiome Therapeutics Product and Solutions

Table 63. PureTech Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 64. Second Genome Corporate Information, Location and Competitors

Table 65. Second Genome Major Business

Table 66. Second Genome Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 67. Second Genome SWOT Analysis

Table 68. Second Genome Microbiome Therapeutics Product and Solutions

Table 69. Second Genome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 70. Ritter Pharmaceuticals Corporate Information, Location and Competitors

Table 71. Ritter Pharmaceuticals Major Business

Table 72. Ritter Pharmaceuticals Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 73. Ritter Pharmaceuticals SWOT Analysis

Table 74. Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions

Table 75. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 76. Azitra Corporate Information, Location and Competitors

Table 77. Azitra Major Business

Table 78. Azitra Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 79. Azitra SWOT Analysis

Table 80. Azitra Microbiome Therapeutics Product and Solutions

Table 81. Azitra Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 82. C3 Jian Corporate Information, Location and Competitors

Table 83. C3 Jian Major Business

Table 84. C3 Jian Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 85. C3 Jian SWOT Analysis

Table 86. C3 Jian Microbiome Therapeutics Product and Solutions

Table 87. C3 Jian Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 88. Osel Corporate Information, Location and Competitors

Table 89. Osel Major Business

Table 90. Osel Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 91. Osel SWOT Analysis

Table 92. Osel Microbiome Therapeutics Product and Solutions

Table 93. Osel Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 94. Symberix Corporate Information, Location and Competitors

Table 95. Symberix Major Business

Table 96. Symberix Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 97. Symberix SWOT Analysis

Table 98. Symberix Microbiome Therapeutics Product and Solutions

Table 99. Symberix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 100. Metabiomics Corporate Information, Location and Competitors

Table 101. Metabiomics Major Business

Table 102. Metabiomics Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 103. Metabiomics SWOT Analysis

Table 104. Metabiomics Microbiome Therapeutics Product and Solutions

Table 105. Metabiomics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 106. Rebiotix Corporate Information, Location and Competitors

Table 107. Rebiotix Major Business

Table 108. Rebiotix Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 109. Rebiotix SWOT Analysis

Table 110. Rebiotix Microbiome Therapeutics Product and Solutions

Table 111. Rebiotix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 112. Symbiotix Biotherapies Microbiome Therapeutics Type and Application

Table 113. Symbiotix Biotherapies Major Business

Table 114. Symbiotix Biotherapies Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 115. Symbiotix Biotherapies SWOT Analysis

Table 116. Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions

Table 117. Symbiotix Biotherapies Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 118. OpenBiome Corporate Information, Location and Competitors

Table 119. OpenBiome Major Business

Table 120. OpenBiome Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 121. OpenBiome SWOT Analysis

Table 122. OpenBiome Microbiome Therapeutics Product and Solutions

Table 123. OpenBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 124. MicroBiome Therapeutics LLC Corporate Information, Location and Competitors

Table 125. MicroBiome Therapeutics LLC Major Business

Table 126. MicroBiome Therapeutics LLC Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 127. MicroBiome Therapeutics LLC SWOT Analysis

Table 128. MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions

Table 129. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 130. Metabogen Corporate Information, Location and Competitors

Table 131. Metabogen Major Business

Table 132. Metabogen Microbiome Therapeutics Total Revenue (USD Million) (2017-2018)

Table 133. Metabogen SWOT Analysis

Table 134. Metabogen Microbiome Therapeutics Product and Solutions

Table 135. Metabogen Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 136. Global Microbiome Therapeutics Revenue (USD Million) by Players (2015-2020)

Table 137. Global Microbiome Therapeutics Revenue Share by Players (2015-2020)

Table 138. Key Players Microbiome Therapeutics Revenue (USD Million) in United States (2015-2020)

Table 139. Key Players Microbiome Therapeutics Revenue Share in United States (2015-2020)

Table 140. North America Microbiome Therapeutics Revenue (USD Million) by Countries (2015-2020)

Table 141. North America Microbiome Therapeutics Revenue Market Share by Countries (2015-2020)

Table 142. North America Microbiome Therapeutics Revenue (USD Million) by Countries (2020-2026)

Table 143. North America Microbiome Therapeutics Revenue Market Share by Countries (2020-2026)

Table 144. Europe Microbiome Therapeutics Revenue (USD Million) by Countries (2015-2020)

Table 145. Europe Microbiome Therapeutics Revenue Market Share by Countries (2015-2020)

Table 146. Europe Microbiome Therapeutics Revenue (USD Million) by Countries (2020-2026)

Table 147. Europe Microbiome Therapeutics Revenue Market Share by Countries (2020-2026)

Table 148. Asia-Pacific Microbiome Therapeutics Revenue (USD Million) by Countries (2015-2020)

Table 149. Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries (2015-2020)

Table 150. Asia-Pacific Microbiome Therapeutics Revenue (USD Million) by Countries (2020-2026)

Table 151. Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries (2020-2026)

Table 152. South America Microbiome Therapeutics Revenue (USD Million) by Countries (2015-2020)

Table 153. South America Microbiome Therapeutics Revenue Market Share by Countries (2015-2020)

Table 154. South America Microbiome Therapeutics Revenue (USD Million) by Countries (2020-2026)

Table 155. South America Microbiome Therapeutics Revenue Market Share by Countries (2020-2026)

Table 156. Middle East & Africa Microbiome Therapeutics Revenue (USD Million) by Countries (2015-2020)

Table 157. Middle East & Africa Microbiome Therapeutics Revenue Market Share by Countries (2015-2020)

Table 158. Middle East & Africa Microbiome Therapeutics Revenue (USD Million) by Countries (2020-2026)

Table 159. Middle East & Africa Microbiome Therapeutics Revenue Market Share by Countries (2020-2026)

Table 160. Global Microbiome Therapeutics Revenue (USD Million) by Type (2015-2020)

Table 161. Global Microbiome Therapeutics Revenue Share by Type (2015-2020)

Table 162. Global Microbiome Therapeutics Revenue Forecast by Type (2020-2025)

Table 163. Global Microbiome Therapeutics Market Share Forecast by Type (2020-2025)

Table 164. United States Microbiome Therapeutics Revenue (USD Million) by Type (2015-2020)

Table 165. United States Microbiome Therapeutics Revenue Share by Type (2015-2020)

Table 166. United States Microbiome Therapeutics Revenue Forecast by Type (2020-2025)

Table 167. United States Microbiome Therapeutics Market Share Forecast by Type (2020-2025)

Table 168. Global Microbiome Therapeutics Revenue (USD Million) by Application (2015-2020)

Table 169. Global Microbiome Therapeutics Revenue Share by Application (2015-2020)

Table 170. Global Microbiome Therapeutics Revenue Forecast by Application (2020-2025)

Table 171. Global Microbiome Therapeutics Market Share Forecast by Application (2020-2025)

Table 172. United States Microbiome Therapeutics Revenue (USD Million) by Application (2015-2020)

Table 173. United States Microbiome Therapeutics Revenue Share by Application (2015-2020)

Table 174. United States Microbiome Therapeutics Revenue Forecast by Application (2020-2025)

Table 175. United States Microbiome Therapeutics Market Share Forecast by Application (2020-2025)

Table 176.List of Figures

Table 177. Microbiome Therapeutics Picture

Table 178. Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 179. Global Microbiome Therapeutics Revenue Market Share by Type in 2019

Table 180. Upper GIT Picture

Table 181. Lower GIT Picture

Table 182. Microbiome Therapeutics Revenue Market Share by Application in 2019

Table 183. Inflammatory Bowel Disease (IBD) Picture

Table 184. Orphan Drug Picture

Table 185. Immuno-oncology Picture

Table 186. Others Picture

Table 187. Global Microbiome Therapeutics Revenue and Growth Rate (2015-2025) (USD Million)

Table 188. Global Microbiome Therapeutics Market Size Share by Regions (2015-2025)

Table 189. Global Microbiome Therapeutics Market Size Share by Regions in 2019

Table 190. Global Microbiome Therapeutics Revenue Market Share by Regions (2020-2025)

Table 191. North America Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)

Table 192. Europe Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)

Table 193. Asia-Pacific Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)

Table 194. South America Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)

Table 195. Middle East & Africa Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)

Table 196. Global Microbiome Therapeutics Revenue Share by Players in 2019

Table 197. Global Top 5 Players Microbiome Therapeutics Revenue Market Share in 2019

Table 198. Top 10 Players Microbiome Therapeutics Revenue Market Share in Global Market in 2019

Table 199. Global Microbiome Therapeutics Market Size (USD Million) by Type (2015-2025)

Table 200. Global Microbiome Therapeutics Market Size Share by Application (2015-2025)

Table 201. North America Microbiome Therapeutics Market Size Share by Countries (2015-2025)

Table 202. North America Microbiome Therapeutics Market Size Share by Countries in 2019

Table 203. United States Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 204. Canada Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 205. Mexico Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 206. Europe Microbiome Therapeutics Market Size Share by Countries (2015-2025)

Table 207. Europe Microbiome Therapeutics Market Size Share by Countries in 2019

Table 208. Germany Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 209. France Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 210. Russia Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 211. Italy Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 212. Spain Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 213. UK Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 214. Asia Microbiome Therapeutics Market Size Share by Countries (2015-2025)

Table 215. Asia Microbiome Therapeutics Market Size Share by Countries in 2019

Table 216. China Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 217. Japan Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 218. Korea Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 219. India Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 220. Southeast Asia Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 221. South America Microbiome Therapeutics Market Size Share by Countries (2015-2025)

Table 222. South America Microbiome Therapeutics Market Size Share by Countries in 2019

Table 223. Brazil Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 224. Argentina Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 225. Middle East & Africa Microbiome Therapeutics Market Size Share by Countries (2015-2025)

Table 226. Middle East & Africa Microbiome Therapeutics Market Size Share by Countries in 2019

Table 227. Saudi Arabia Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 228. UAE Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 229. Egypt Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 230. South Africa Microbiome Therapeutics Market Size (USD Million) and Forecast (2015-2025)

Table 231. Global Microbiome Therapeutics Revenue Share by Type (2015-2020)

Table 232. United States Microbiome Therapeutics Revenue Share by Type (2015-2020)

Table 233. Global Microbiome Therapeutics Revenue Share by Application (2015-2020)

Table 234. United States Microbiome Therapeutics Revenue Share by Application (2015-2020)